Phase 1 Depression and Anxiety Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are male or female and do not smoke.
- People who have no significant health concerns found during their screening assessments, as determined by the trial doctor.
- People whose body mass index (a measure of body weight relative to height) falls between 18.5 and 29.9 kg/m², including those exact values.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a past or current skin condition — such as atopy, psoriasis, eczema, chronic or atopic dermatitis, vitiligo, or hives — that the trial doctor believes could affect the safety of the participant or the reliability of the study results.
- People with a history or current signs of chronic infectious disease, disorders affecting the whole body, seizure disorders, or heart and blood vessel conditions (particularly high blood pressure or a family history of sudden cardiac death), as determined by the trial doctor.
- People with a history of a condition that could significantly affect how the immune system responds, such as immune deficiencies (including HIV or AIDS), severe allergic conditions (such as anaphylaxis, asthma, or widespread drug reactions), certain cancers affecting the blood or lymph system (such as lymphoma or leukemia), rheumatoid arthritis, or lupus.
- People who have had a significant illness in the four weeks before their screening visit.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (616) 656-4563
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Assessment of irritation; Assessment of sensitization
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.